Treatment of Hereditary Angioedema With Plasma-Derived C1 Inhibitor: A Review. [PDF]
Martinez-Saguer I +3 more
europepmc +1 more source
Population-scale analysis reveals inherited C1-inhibitor deficiency is a polyphenotypic thrombotic disorder. [PDF]
Rodriguez Espada A +15 more
europepmc +1 more source
C1 inhibitor deficiency enhances contact pathway-mediated activation of coagulation and venous thrombosis. [PDF]
Grover SP +16 more
europepmc +1 more source
Berotralstat effectiveness and safety in patients with hereditary angioedema with normal C1 inhibitor. [PDF]
Buckland MS +3 more
europepmc +1 more source
Health-related quality of life in hereditary angioedema patients treated with subcutaneous C1 inhibitor (C1-INH) therapy in Canada. [PDF]
Waserman S +16 more
europepmc +1 more source
A Retrospective Analysis of Long-Term Prophylaxis with Berotralstat in Patients with Hereditary Angioedema and Acquired C1-Inhibitor Deficiency-Real-World Data. [PDF]
Johnson F +9 more
europepmc +1 more source
Clinical validity of dried blood spot assay for the measurement of functional C1 inhibitor in angioedema due to C1 inhibitor deficiency. [PDF]
Bernstein JA +6 more
europepmc +1 more source
Acquired Angioedema Related to Transient C1- Inhibitor Deficiency Triggered by <i>Mycoplasma pneumoniae</i> Infection: A Case Report. [PDF]
Peristeri AM +6 more
europepmc +1 more source
Rapid resolution of erythema marginatum after icatibant in acquired angioedema [PDF]
Broesby-Olsen, Sigurd, Bygum, Anette
core +1 more source
Expanding the Genetic and Clinical Spectrum of Hereditary Angioedema with Normal C1 Inhibitor: Novel Variants and Treatment Insights. [PDF]
Gao H +18 more
europepmc +1 more source

